These findings agree with another study in which the cancer drivers were compared between CIN− and CIN+ tumors in mice, which found that CIN+ but not CIN− cancers alleviate STAT1 and IFN inflammatory signaling (Schubert et al. 2021). The gene discussed is STAT1; the disease is cancer.